Propoclear is a drug owned by ZOETIS INC. It is protected by 1 US drug patent filed in 2023. All patents have expired. Details of Propoclear’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
Exclusivity Information
Propoclear holds 1 exclusivity out of which 1 has expired. Details of Propoclear's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | May 21, 2013 |
About Propoclear
Propoclear is a drug
owned by ZOETIS INC.
Propoclear uses
Propofol as the active
ingredient.
Active Ingredient:
Propoclear uses
Propofol as the active ingredient.
Check out other Drugs and Companies using
Propofol ingredient.